Repeated allergen exposure enhances excitatory nonadrenergic noncholinergic nerve-mediated bronchoconstriction in sensitized guinea-pigs

European Respiratory Journal

Volumn 9, Issue 7, 1996, Pages 1439-1444

  Kageyama, N ^a   Ichinose, M ^a   Igarashi, A ^a   Miura, M ^a   Yamauchi, H ^a   Sasaki, Y ^a   Ishikawa, J ^a   Tomaki, M ^a   Shirato, K ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

airway inflammation; antigen; asthma; neutral endopeptidase; substance P

Indexed keywords

ALLERGEN; ATROPINE; ENKEPHALINASE INHIBITOR; NEUROKININ A; OVALBUMIN; PHOSPHORAMIDON; PROPRANOLOL; SODIUM CHLORIDE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CONTROLLED STUDY; ELECTROSTIMULATION; GUINEA PIG; MALE; MUSCLE ISOMETRIC CONTRACTION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ALLERGENS; ANIMALS; BRONCHI; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; ELECTRIC STIMULATION; GUINEA PIGS; LUNG; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NEUROKININ A; OVALBUMIN; SUBSTANCE P;

EID: 0030018031     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09071439     Document Type: Article

References (38)

1. Barnes PJ. Neural control of human airways in health and disease. Am Rev Respir Dis 1986; 134: 1289-1314.
2. Barnes PJ . Asthma as an axon reflex. Lancet 1986; i: 242-245.
3. Lundberg JM, Lundblad L, Änggård A, et al. Bioactive peptides in capsaicin-sensitive C-fiber afferents of the airways: functional and pathophysiological implications. In: Kaliner M, Barnes PJ, eds. The Airways: Neural Control in Health and Disease. New York, Marcel Dekker, 1987; pp. 417-445.
4. Peatfield AC, Richardson PS. Evidence for noncholinergic, nonadrenergic nervous control of mucus secretion into the cat trachea. J Physiol 1983; 342: 335-345.
5. Lundberg JM, Saria A, Brodin E, Rosell S, Folkers K. A substance P antagonist inhibits vagally-induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea-pig. Proc Natl Acad Sci USA 1983; 80: 1120-1124.
6. Ichinose M, Belvisi MG, Barnes PJ. Bradykjnin-induced bronchoconstriction in guinea-pig in vivo: role of neural mechanisms. J Pharmacol Exp Ther 1990; 253: 594-599.
7. Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ. Bradykinin-induced bronchoconstriction in humans: mode of action. Am Rev Respir Dis 1987; 135: 176-180.
8. Ichinose M, Nakajima N, Takahashi T, Yamauchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 1992; 340: 1248-1251.
9. Ellis JL, Undem BJ. Antigen-induced enhancement of noncholinergic contractile responses to vagus nerve and electrical field stimulation in guinea-pig isolated trachea. J Pharmacol Exp Ther 1992; 262: 646-653.
10. Andersson P. Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pigs. Allergy 1980; 35: 65-71.
11. Undem BJ, Myers AC, Barthlow H, Weinreich D. Vagal innervation of guinea-pig bronchial smooth muscle. J Appl Physiol 1990; 69: 1336-1346.
12. Lundberg JM, Saria A, Brodin E, Rosell S, Folkers K. A substance P antagonist inhibits vagally-induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea-pig. Proc Natl Acad Sci USA 1983; 80: 1120-1124.
13. Taylor SM, Paré PD, Schellenberg RR. Cholinergic and nonadrenergic mechanisms in human and guinea-pig airways. J Appl Physiol: Respirat Environ Exercise Physiol 1984; 56: 958-965.
14. Naline E, Devillier P, Drapeau G, et al. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. Am Rev Respir Dis 1989; 140: 679-686.
15. Barnes PJ, Baraniuk JN, Belvisi MG. State of the art: neuropeptides in the respiratory tract. Part I. Am Rev Respir Dis 1991; 144: 1187-1198.
16. Regoli D, Drapeau G, Dion S, D'Orléans-Juste P. Pharmacological receptors for substance P and neurokinins. Life Sci 1987; 40: 109-117.
17. Freidin M, Kessler JA. Cytokine regulation of substance P expression in sympathetic neurons. Proc Natl Acad Sci USA 1991; 88: 3200-3203.
18. Hart RP, Shadiack AM, Jonakait GM. Substance P gene expression is regulated by interleukin-1 in cultured sympathetic ganglia. J Neurosci Res 1991; 29: 282-291.
19. Hurst SM, Stanisz AM, Sharkey KA, Collins SM. Interleukin 1β-induced increase in substance P in rat myenteric plexus. Gastroenterology 1993; 105: 1754-1760.
20. Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, Rosenwasser LJ. Detection of alveolar macrophage-derived IL-1β in asthma: inhibition with corticosteroids. J Immunol 1992; 149: 3078-3082.
21. Del Pozo V, De Andres B, Martin E, et al. Murine eosinophils and IL-1: IL-1α mRNA detection by in situ hybridization. Production and release of IL-1 from peritoneal eosinophils. J Immunol 1990; 144: 3117-3122.
22. Miossec P, Cavender D, Ziff M. Production of interleukin-1 by human endothelial cells. J Immunol 1986; 136: 2486-2491.
23. Marucha PT, Zeff RA, Kreutzer DL. Cylokine regulation of IL-1β gene expression in the human polymorphonuclear leukocyte. J Immunol 1990; 145: 2932-2937.
24. Otten U. Nerve growth factor and the peptidergic sensory neurons. Trends Phamacol Sci 1984; 5: 307-310.
25. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptides genes in adult sensory neurons. Nature 1989; 337: 362-364.
26. Gilchrist CA, Morrison C, Harmar AJ. Regulation of preprotachykinin gene expression by nerve growth factor. In: Leeman SE, Krause JE, Lembeck F, eds. Substance P and related peptides: cellular and molecular physiology. Am NY Acad Sci 1991; 632: 391-393.
27. Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in nonneuronal cells of rat sciatic nerve. Nature 1987; 330: 658-659.
28. Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J 1991; 4: 673-682.
29. Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G. Substance P and β-endorphin-like immuno-reactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 1992; 90: 646-652.
30. Tomaki M, Ichinose M, Miura M, et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995; 151: 613-617.
31. Howarth PH, Djukanovic R, Wilson JW, Holgate ST, Springall DR, Polak JM. Mucosal nerves in endobronchial biopsies in asthma and nonasthma. Int Arch Allergy Appl Immunol 1991; 94: 330-333.
32. Howarth PH, Springall DR, Redington AE, Djukanovic R, Holgate ST, Polak JM. Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. Am Rev Respir Cell Mol Biol 1995; 13: 288-296.
33. Nadel JA. Neutral endopeptidase modulates neurogenic inflammation. Eur Respir J 1991; 4: 745-754.
34. Djokic TD, Nadel JA, Dusser DJ, Sekizawa K, Graf PD, Borson DB. Inhibitors of neutral endopeptidase potentiate electrically- and capsaicin-induced noncholinergic contraction in guinea-pig bronchi. J Pharmacol Exp Ther 1989; 248: 7-11.
35. Frossard N, Rhoden KJ, Barnes PJ. Influence of epithelium on guinea-pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther 1989; 248: 292-298.
36. Sekizawa K, Tamaoki J, Nadel JA, Borson DB. Enkephalinase inhibitor potentiates substance P- and electrically-induced contraction in ferret trachea. J Appl Physiol 1987; 63: 1401-1405.
37. Lilly CM, Kobzik L, Hall AE, Drazen JM. Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea-pig lungs. J Clin Invest 1994; 93: 2667-2674.
38. Lundberg JM, Brodin E, Saria A. Effects and distribution of vagal capsaicin-sensitive substance P neurons with special reference to the trachea and lungs. Acta Physiol Scand 1983; 119: 243-252.